Search Results - "Margol, Ashley S."

Refine Results
  1. 1
  2. 2
  3. 3

    Pathology and diagnosis of SMARCB1-deficient tumors by Margol, Ashley S, Judkins, Alexander R

    Published in Cancer genetics (01-09-2014)
    “…Malignant rhabdoid tumor (MRT) can occur in the kidney, central nervous system, or extracranial/extrarenal locations and is characterized by alterations in the…”
    Get full text
    Journal Article
  4. 4

    Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy by Toll, Stephanie A., Tran, Hung N., Cotter, Jennifer, Judkins, Alexander R., Tamrazi, Benita, Biegel, Jaclyn A., Dhall, Girish, Robison, Nathan J., Waters, Kaaren, Patel, Palak, Cooper, Robert, Margol, Ashley S.

    Published in Oncotarget (11-01-2019)
    “…Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive treatment strategies. The use of targeted therapy for BRAFV600E mutated…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship—A Review by Ronsley, Rebecca, Cole, Bonnie, Ketterl, Tyler, Wright, Jason, Ermoian, Ralph, Hoffman, Lindsey M., Margol, Ashley S., Leary, Sarah E.S.

    Published in Pediatric neurology (01-12-2024)
    “…Central nervous system (CNS) embryonal tumors represent a diverse group of neoplasms and have a peak incidence in early childhood. These tumors can be located…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group by Margol, Ashley S., Yeo, Kee Kiat, Xia, Caihong, Onar, Arzu, Robison, Nathan J., Freyer, David R., Dhall, Girish

    Published in Journal of neuro-oncology (01-12-2018)
    “…Background For several types of cancer, biological differences and outcome disparities have been documented in adolescents/young adults (AYAs, 15–39 years old)…”
    Get full text
    Journal Article
  12. 12

    Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens by Yeo, Kee Kiat, Margol, Ashley S., Kennedy, Rebekah J., Hung, Long, Robison, Nathan J., Dhall, Girish, Asgharzadeh, Shahab

    Published in Journal of neuro-oncology (01-11-2019)
    “…Purpose Irradiation-avoiding strategies have been used with relative success in the treatment of infants and young children with medulloblastoma. While…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Multi‐institutional analysis of central nervous system germ cell tumors in patients with Down syndrome by Harris, Micah K., Graham, Richard T., Cappellano, Andréa M., Margol, Ashley S., Michaiel, George, Crawford, John R., Ioakeim‐Ioannidou, Myrsini, Stanek, Joseph R., Liu, Kevin X., MacDonald, Shannon M., Abdelbaki, Mohamed S.

    Published in Pediatric blood & cancer (01-10-2022)
    “…Purpose Primary germ cell tumors (GCTs) are the most common central nervous system (CNS) neoplasm in patients with Down syndrome (DS). However, a standard of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effective re-induction regimen for children with recurrent medulloblastoma by O’Halloran, Katrina, Phadnis, Sheetal, Friedman, Gregory K, Metrock, Katie, Davidson, Tom B, Robison, Nathan J, Tamrazi, Benita, Cotter, Jennifer A, Dhall, Girish, Margol, Ashley S

    Published in Neuro-oncology advances (10-05-2024)
    “…Abstract Background There is no standard treatment for the recurrence of medulloblastoma, the most common malignant childhood brain tumor, and prognosis…”
    Get full text
    Journal Article
  20. 20